REFERENCES
- Bassetti D. Chemioterapici antinfettivi e loro impiego razionale. VI Ed. Intramed Communications 1990.
- Paradisi F. Terapia delle infezioni. II Ed. Torino UTET, 1992.
- Rossi F, Calderaro V, Cazzola M, et al. Le basi farmaco-logiche della medicina. In Professione Medico, Torino, UTET. 1997.
- Cazzola M. Problems and perspectives in the antibiotic treatment of lower respiratory tract infections. Pulm Pharmacol 1994; 7: 139–52.
- Niederman MS, Bass JB Jr, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of the severity, and initial antimicrobial therapy. Am Rev Resp Dis 1993; 148: 1418–26.
- The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to hospital. Br J Hosp Med 1993; 49: 346–50.
- Mandell LA, Niederman M. The Canadian Community-Acquired Pneumonia Consensus Conference Group. Antimicrobial treatment of community-acquired pneumonia in adults: a conference report. Can J Infect Dis 1993; 4: 25.
- Bartlett JG, Breiman RF, Mandell LA, File TMJr. Community-acquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811–38.
- The Centers for Disease Control and Prevention and the American Academy of Pediatrics. Principles of judicious use of antimicrobial agents for pediatric upper respiratory tract infections. Pediatrics 1998; 101 (1, part 2 of 2).
- Paradisi F, Corti G. Treatment of otitis media. Curr Opin Infect Dis 1998; 11: 659–65.
- Caffari B, Di Giovanbattista G, Cattaruzzi C, Mazzolani M, Vaccheri A. La lista delle DDD del DURG-Italia. Giorn Ital Farmacol Clin 1995; 9: 83–156.
- Vernejoux JM, Texier-Mauguein J, Rio P, Guizard AV, Tunon de Lara JM, Taytard A. Bacterial infectious agents implicated in lower respiratory tract infections in general practice. Rev Pneumol Clin 1997; 53: 138–43.
- Jones RN, Jacobs MR, Washington JA, Pfaller MA. A 1994-95 survey of Haemophilus influenzae susceptibility to ten orally administered agents. A 187 clinical laboratory center sample in the United States. Diagn Microbiol Infect Dis 1997; 27: 75–83.
- Jorgensen JH. Update on mechanisms and prevalence of antimicrobial resistance in Haemophilus influenzae. Clin Infect Dis 1992; 14: 1119–23.
- Rutman A, Dowling R, Wills P, Feldman C, Cole PJ, Wilson R. Effect of dirithromycin on Haemophilus influenzae infection of the respiratory mucosa. Antimicrob Agents Chemother 1998; 42: 772–8.
- Vogel F. Therapy of airway infections. Dsch Med Wochenschr 1996; 121: 1195–7.
- DeGroot R, Dzoljic-Danilovic G, vanKlingeren B, Goessens WHF, Neyens HJ. Antibiotic resistance in Haemophilus influenzae: mechanisms, clinical importance and consequences for therapy. Eur J Pediatr 1991; 150: 534–46.
- Appelbaum PC. Antiomicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 1992; 15: 77–83.
- Dowell SF, Schwartz B. Resistant pneumococci: protecting patients through judicious use of antibiotics. Am Fam Phys 1997; 55: 1647–54.
- Jacobs MR. Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 1992; 15: 119–27.
- Brandli O, Luterbacher T, Egli N. When and why are antibiotics indicated in airway infections (except pneumonia)? Schweiz Rundsch Med Prax 1997; 86: 737–40.